Onconic Therapeutics
Korea - SeoulBiotechnology
Focus: Onconic Therapeutics is a Korea-based biotechnology company specializing in small molecule drug development. Limited public data available on company scale and market position.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Onconic Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Onconic Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
coadministration of JP-1366 and aceclofenac
Anti-Ulcer AgentsClinical Trials (1)
NCT05181124Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian
Phase 1Help build intelligence for Onconic Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.